Operating Expenses Summary of Excelsior Medical Co., Ltd.

Excelsior Medical Co., Ltd.'s latest annual operating expenses in 2023 was 919.21 Million TWD , up 2.9% from previous year.
Excelsior Medical Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 237.74 Million TWD , up 6.54% from previous quarter.
Excelsior Medical Co., Ltd. reported a annual operating expenses of 893.28 Million TWD in annual operating expenses 2022, up 15.93% from previous year.
Excelsior Medical Co., Ltd. reported a annual operating expenses of 770.54 Million TWD in annual operating expenses 2021, down -0.52% from previous year.
Excelsior Medical Co., Ltd. reported a quarterly operating expenses of 233.27 Million TWD for 2024 Q1, down -3.03% from previous quarter.
Excelsior Medical Co., Ltd. reported a quarterly operating expenses of 240.54 Million TWD for 2023 Q4, down -1.72% from previous quarter.

Annual Operating Expenses Chart of Excelsior Medical Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Excelsior Medical Co., Ltd. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	919.21 Million TWD	2.9%
2022	893.28 Million TWD	15.93%
2021	770.54 Million TWD	-0.52%
2020	774.59 Million TWD	0.56%
2019	770.29 Million TWD	2.86%
2018	748.86 Million TWD	-0.72%
2017	754.32 Million TWD	-7.81%
2016	818.22 Million TWD	-7.32%
2015	882.84 Million TWD	5.42%
2014	837.45 Million TWD	-1.02%
2013	846.12 Million TWD	-13.0%
2012	972.57 Million TWD	4.22%
2011	933.21 Million TWD	-11.31%
2010	1.05 Billion TWD	13.45%
2009	927.49 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	237.74 Million TWD	6.54%
2024 Q1	233.27 Million TWD	-3.03%
2023 Q4	240.54 Million TWD	-1.72%
2023 Q2	236.79 Million TWD	0.22%
2023 Q3	244.75 Million TWD	3.36%
2023 FY	919.21 Million TWD	2.9%
2023 Q1	236.26 Million TWD	-1.77%
2022 Q2	200.3 Million TWD	-10.16%
2022 Q3	229.51 Million TWD	14.58%
2022 Q4	240.52 Million TWD	4.8%
2022 FY	893.28 Million TWD	15.93%
2022 Q1	222.94 Million TWD	4.88%
2021 FY	770.54 Million TWD	-0.52%
2021 Q3	186.82 Million TWD	0.75%
2021 Q4	212.58 Million TWD	13.79%
2021 Q1	186.3 Million TWD	-5.69%
2021 Q2	185.42 Million TWD	-0.47%
2020 Q2	180.42 Million TWD	-4.04%
2020 Q1	188.02 Million TWD	-8.37%
2020 Q3	208.6 Million TWD	15.62%
2020 Q4	197.54 Million TWD	-5.3%
2020 FY	774.59 Million TWD	0.56%
2019 Q2	193.65 Million TWD	4.15%
2019 Q4	205.2 Million TWD	10.62%
2019 FY	770.29 Million TWD	2.86%
2019 Q1	185.93 Million TWD	1.29%
2019 Q3	185.5 Million TWD	-4.21%
2018 Q4	183.57 Million TWD	-1.01%
2018 FY	748.86 Million TWD	-0.72%
2018 Q3	185.43 Million TWD	-9.81%
2018 Q2	205.6 Million TWD	17.99%
2018 Q1	174.25 Million TWD	-16.85%
2017 Q3	203.39 Million TWD	13.33%
2017 Q1	161.89 Million TWD	-22.76%
2017 Q2	179.48 Million TWD	10.87%
2017 FY	754.32 Million TWD	-7.81%
2017 Q4	209.56 Million TWD	3.03%
2016 Q1	191.44 Million TWD	-9.92%
2016 Q2	219.02 Million TWD	14.4%
2016 Q3	198.16 Million TWD	-9.52%
2016 Q4	209.59 Million TWD	5.77%
2016 FY	818.22 Million TWD	-7.32%
2015 Q2	219.25 Million TWD	-0.05%
2015 Q1	219.36 Million TWD	-6.4%
2015 FY	882.84 Million TWD	5.42%
2015 Q3	231.69 Million TWD	5.68%
2015 Q4	212.54 Million TWD	-8.27%
2014 Q4	234.35 Million TWD	13.27%
2014 Q3	206.9 Million TWD	2.33%
2014 Q1	193.99 Million TWD	0.45%
2014 FY	837.45 Million TWD	-1.02%
2014 Q2	202.19 Million TWD	4.22%
2013 Q3	207.23 Million TWD	-9.14%
2013 Q1	217.66 Million TWD	-14.16%
2013 FY	846.12 Million TWD	-13.0%
2013 Q4	193.13 Million TWD	-6.8%
2013 Q2	228.08 Million TWD	4.79%
2012 Q4	253.56 Million TWD	8.57%
2012 Q3	233.55 Million TWD	-7.31%
2012 Q2	251.96 Million TWD	6.45%
2012 FY	972.57 Million TWD	4.22%
2012 Q1	236.71 Million TWD	80.83%
2011 Q2	274.76 Million TWD	6.72%
2011 Q1	257.47 Million TWD	-22.18%
2011 FY	933.21 Million TWD	-11.31%
2011 Q4	130.9 Million TWD	-51.53%
2011 Q3	270.06 Million TWD	-1.71%
2010 Q3	245.92 Million TWD	-6.61%
2010 FY	1.05 Billion TWD	13.45%
2010 Q4	330.86 Million TWD	34.54%
2010 Q1	212.07 Million TWD	0.0%
2010 Q2	263.32 Million TWD	24.16%
2009 FY	927.49 Million TWD	0.0%

Peer Operating Expenses Comparison of Excelsior Medical Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Apex Medical Corp.	944.09 Million TWD	2.636%
OK Biotech Co., Ltd.	216.37 Million TWD	-324.827%
Applied BioCode Corporation	455.44 Million TWD	-101.829%

Global Stocks Search

Excelsior Medical Co., Ltd. (4104.TW)

Operating Expenses Summary of Excelsior Medical Co., Ltd.

Annual Operating Expenses Chart of Excelsior Medical Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Excelsior Medical Co., Ltd. (2023 - 2009)

Peer Operating Expenses Comparison of Excelsior Medical Co., Ltd.